Regenerx Biopharmaceuticals Inc
RGRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000707511
Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Regenerx Biopharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Regenerx Biopharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Essetifin SPA | 10% Owner | – | Jul 6, 2023 | 0 |
| Cavazza Paolo | 10% Owner | 1,500,000Indirect | Jul 6, 2023 | 0 |
| Aptafin S P A | Other: Member of 10% owner group | – | Jul 6, 2023 | 0 |
| Cavazza Francesca | 10% Owner | – | Jul 6, 2023 | 0 |
| Cavazza Silvia | 10% Owner | – | Jul 6, 2023 | 0 |
| Cavazza Enrico | 10% Owner | – | Jul 6, 2023 | 0 |
| Cavazza Preta Martina | 10% Owner | – | Jul 6, 2023 | 0 |
| Goldstein Allan L | Director | 1,507,793 | May 19, 2022 | 0 |
| Finkelstein J J | President and CEO | 1,712,991 | May 19, 2022 | 0 |
| McNay Joseph C | Director | – | May 19, 2022 | 0 |
| Elsey R Don | Director | – | May 19, 2022 | 0 |
| Bove Mauro | Director | – | May 19, 2022 | 0 |
| Noseda Alessandro | Director | – | May 19, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 (view filing)4:16 PM ET | Jun 30 | 2 days | Cavazza Paolo10% Owner | PPurchase | +1.50M | $0.20 | +$300.0K | New position1.50M after | |
| Jul 6, 2021 (view filing)4:34 PM ET | Jun 30 | 6 daysLate | Goldstein Allan LDirector | PPurchase | +125.0K | $0.20 | +$25.0K | +8.3%1.64M after | |
| Jul 6, 2021 (view filing)4:34 PM ET | Jun 30 | 6 daysLate | Goldstein Allan LDirector | PPurchase | +187.5K | $0.00 | $0 | –93.8K after | Derivative2 lots |
| Jul 6, 2021 (view filing)4:35 PM ET | Jun 30 | 6 daysLate | Finkelstein J JPresident and CEO | PPurchase | +75.0K | $0.20 | +$15.0K | +4.6%1.71M after | |
| Jul 6, 2021 (view filing)4:35 PM ET | Jun 30 | 6 daysLate | Finkelstein J JPresident and CEO | PPurchase | +112.5K | $0.00 | $0 | –56.3K after | Derivative2 lots |
| Jul 6, 2023 (view filing)4:30 PM ET | Jul 3 | 3 days | Essetifin SPA and 6 others10% Owner | PPurchaseConvertible Promissory Note (right to buy) | – | – | – | – | DerivativePrice outlier |